Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.
Luckily for you, our job at StockStory is to help you avoid short-term fads by pointing you toward high-quality businesses that can generate sustainable long-term growth. On that note, here are three growth stocks where the best is yet to come.
Toast (TOST)
One-Year Revenue Growth: +24.1%
Born from the frustrations of three friends waiting too long for their restaurant bill, Toast (NYSE: TOST) provides a cloud-based digital technology platform with software, payment processing, and hardware solutions built specifically for restaurants.
Why Could TOST Be a Winner?
- ARR trends over the last year show it’s maintaining a steady flow of long-term contracts that contribute positively to its revenue predictability
- Forecasted revenue growth of 20.5% for the next 12 months indicates its momentum over the last two years is sustainable
Toast is trading at $27.58 per share, or 2.3x forward price-to-sales. Is now the time to initiate a position? See for yourself in our full research report, it’s free.
Federal Signal (FSS)
One-Year Revenue Growth: +17.1%
Developing sirens that warned of air raid attacks or fallout during the Cold War, Federal Signal (NYSE: FSS) provides safety and emergency equipment for government agencies, municipalities, and industrial companies.
Why Is FSS a Good Business?
- Impressive 14% annual revenue growth over the last five years indicates it’s winning market share this cycle
- Additional sales over the last two years increased its profitability as the 28% annual growth in its earnings per share outpaced its revenue
- Free cash flow margin jumped by 5.1 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
Federal Signal’s stock price of $105.43 implies a valuation ratio of 22.7x forward P/E. Is now the right time to buy? Find out in our full research report, it’s free.
Natera (NTRA)
One-Year Revenue Growth: +38.2%
Founded in 2003 as Gene Security Network before rebranding in 2012, Natera (NASDAQ: NTRA) develops and commercializes genetic tests for prenatal screening, cancer detection, and organ transplant monitoring using its proprietary cell-free DNA technology.
Why Do We Love NTRA?
- Average unit sales growth of 19.5% over the past two years reflects steady demand for its products
- Adjusted operating profits increased over the last two years as the company gained some leverage on its fixed costs and became more efficient
- Free cash flow turned positive over the last five years, indicating the company has achieved financial self-sustainability
At $186.11 per share, Natera trades at 10.3x forward price-to-sales. Is now a good time to buy? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
